Provided by Tiger Fintech (Singapore) Pte. Ltd.

Evotec SE

3.97
+0.390010.89%
Post-market: 3.970.00000.00%16:13 EDT
Volume:339.66K
Turnover:1.33M
Market Cap:1.41B
PE:-6.91
High:3.97
Open:3.77
Low:3.77
Close:3.58
Loading ...

U.S.-Listed Shares of Evotec Down 19.8% Premarket

THOMSON REUTERS
·
22 Nov 2024

Sector Update: Health Care Stocks Advance Premarket Friday

MT Newswires Live
·
22 Nov 2024

Update: Halozyme Therapeutics Withdraws Proposal to Acquire Evotec

MT Newswires Live
·
22 Nov 2024

Halozyme gains after withdrawing Evotec bid

seekingalpha
·
22 Nov 2024

Halozyme withdraws $2.1 bln buyout offer for Evotec

Reuters
·
22 Nov 2024

Halozyme withdraws proposal to acquire Evotec for EUR 11.00 per share in cash

TIPRANKS
·
22 Nov 2024

Halozyme Therapeutics Withdraws Proposal to Acquire Evotec, Bloomberg Reports

MT Newswires Live
·
22 Nov 2024

Press Release: National Bank Investments Announces the Estimated Annual Distribution Amount for the EVO ETF

Dow Jones
·
22 Nov 2024

Is Evotec SE (EVO) the Best German Stock to Buy Now?

Insider Monkey
·
20 Nov 2024

Halozyme says EUR2 billion takeover of Evotech would create leader in drug discovery

Dow Jones
·
18 Nov 2024

Halozyme to Fund Proposed Evotec Takeover in Cash, CEO Says

Bloomberg
·
18 Nov 2024

Key deals this week: Exxon, Unilever, Cardinal Health, Charter Communications and more

seekingalpha
·
17 Nov 2024

Sector Update: Health Care Stocks Slide Late Afternoon

MT Newswires Live
·
16 Nov 2024

Sector Update: Health Care Stocks Retreat Friday Afternoon

MT Newswires Live
·
16 Nov 2024

Halozyme Therapeutics sinks after confirming $2B Evotec buyout offer

seekingalpha
·
16 Nov 2024

Large Pharma Partner Halozyme Therapeutics Offers To Acquire Germany-Based Evotec For ~$2 Billion

Benzinga
·
16 Nov 2024

JPMorgan thinks may take time for market to digest Halozyme bid for Evotec

TIPRANKS
·
15 Nov 2024

BUZZ-Evotec seen up on 2 bln euro buyout offer from Halozyme

Reuters
·
15 Nov 2024

Halozyme Proposes to Acquire Evotec for 11 Euros per Share

MT Newswires Live
·
15 Nov 2024

Halozyme confirms proposal to combine with Evotec for EUR 11.00 per share cash

TIPRANKS
·
15 Nov 2024